Logo image of RAY

RAYTECH HOLDING LTD (RAY) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:RAY - VGG7385S1193 - Common Stock

2.15 USD
+0.02 (+0.94%)
Last: 1/7/2026, 8:00:01 PM
2.19 USD
+0.04 (+1.86%)
After Hours: 1/7/2026, 8:00:01 PM
Fundamental Rating

6

Overall RAY gets a fundamental rating of 6 out of 10. We evaluated RAY against 21 industry peers in the Distributors industry. RAY gets an excellent profitability rating and is at the same time showing great financial health properties. RAY has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

RAY had positive earnings in the past year.
In the past year RAY had a positive cash flow from operations.
Each year in the past 5 years RAY has been profitable.
Each year in the past 5 years RAY had a positive operating cash flow.
RAY Yearly Net Income VS EBIT VS OCF VS FCFRAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 13.62%, RAY belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
RAY has a better Return On Equity (16.79%) than 71.43% of its industry peers.
With a decent Return On Invested Capital value of 11.76%, RAY is doing good in the industry, outperforming 76.19% of the companies in the same industry.
RAY had an Average Return On Invested Capital over the past 3 years of 21.00%. This is significantly above the industry average of 15.42%.
The 3 year average ROIC (21.00%) for RAY is well above the current ROIC(11.76%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 13.62%
ROE 16.79%
ROIC 11.76%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
RAY Yearly ROA, ROE, ROICRAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

Looking at the Profit Margin, with a value of 10.59%, RAY belongs to the top of the industry, outperforming 95.24% of the companies in the same industry.
In the last couple of years the Profit Margin of RAY has declined.
Looking at the Operating Margin, with a value of 9.48%, RAY belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
In the last couple of years the Operating Margin of RAY has declined.
With a decent Gross Margin value of 22.10%, RAY is doing good in the industry, outperforming 66.67% of the companies in the same industry.
RAY's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9.48%
PM (TTM) 10.59%
GM 22.1%
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
RAY Yearly Profit, Operating, Gross MarginsRAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 5 10 15 20 25

9

2. Health

2.1 Basic Checks

RAY has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
RAY has more shares outstanding than it did 1 year ago.
RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RAY Yearly Shares OutstandingRAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 200K 400K 600K 800K 1M
RAY Yearly Total Debt VS Total AssetsRAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

RAY has an Altman-Z score of 4.75. This indicates that RAY is financially healthy and has little risk of bankruptcy at the moment.
RAY has a better Altman-Z score (4.75) than 61.90% of its industry peers.
RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.75
ROIC/WACC1.19
WACC9.9%
RAY Yearly LT Debt VS Equity VS FCFRAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 20M 40M 60M

2.3 Liquidity

A Current Ratio of 5.29 indicates that RAY has no problem at all paying its short term obligations.
RAY's Current ratio of 5.29 is amongst the best of the industry. RAY outperforms 85.71% of its industry peers.
A Quick Ratio of 5.19 indicates that RAY has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 5.19, RAY belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.29
Quick Ratio 5.19
RAY Yearly Current Assets VS Current LiabilitesRAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.81% over the past year.
Measured over the past years, RAY shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.13% on average per year.
RAY shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.00%.
The Revenue has been growing by 20.41% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)14.81%
EPS 3Y-4.13%
EPS 5YN/A
EPS Q2Q%-23.48%
Revenue 1Y (TTM)22%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%17.57%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RAY Yearly Revenue VS EstimatesRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 1.41, the valuation of RAY can be described as very cheap.
Based on the Price/Earnings ratio, RAY is valued cheaper than 100.00% of the companies in the same industry.
When comparing the Price/Earnings ratio of RAY to the average of the S&P500 Index (26.92), we can say RAY is valued rather cheaply.
Industry RankSector Rank
PE 1.41
Fwd PE N/A
RAY Price Earnings VS Forward Price EarningsRAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

85.71% of the companies in the same industry are more expensive than RAY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 7.32
EV/EBITDA -3.44
RAY Per share dataRAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

RAY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for RAY!.
Industry RankSector Rank
Dividend Yield 0%

RAYTECH HOLDING LTD

NASDAQ:RAY (1/7/2026, 8:00:01 PM)

After market: 2.19 +0.04 (+1.86%)

2.15

+0.02 (+0.94%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.18%
Inst Owner ChangeN/A
Ins Owners19.79%
Ins Owner ChangeN/A
Market Cap5.85M
Revenue(TTM)121.99M
Net Income(TTM)12.92M
AnalystsN/A
Price TargetN/A
Short Float %1.17%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 1.41
Fwd PE N/A
P/S 0.37
P/FCF 7.32
P/OCF 7.32
P/B 0.59
P/tB 0.59
EV/EBITDA -3.44
EPS(TTM)1.52
EY70.7%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.29
FCFY13.66%
OCF(TTM)0.29
OCFY13.66%
SpS5.76
BVpS3.63
TBVpS3.63
PEG (NY)N/A
PEG (5Y)N/A
Graham Number11.15
Profitability
Industry RankSector Rank
ROA 13.62%
ROE 16.79%
ROCE 15.03%
ROIC 11.76%
ROICexc N/A
ROICexgc N/A
OM 9.48%
PM (TTM) 10.59%
GM 22.1%
FCFM 5.1%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)26.84%
ROCE(5y)49.77%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
F-Score4
Asset Turnover1.29
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 53.78%
Profit Quality 48.14%
Current Ratio 5.29
Quick Ratio 5.19
Altman-Z 4.75
F-Score4
WACC9.9%
ROIC/WACC1.19
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)135.97%
Profit Quality(5y)122.72%
High Growth Momentum
Growth
EPS 1Y (TTM)14.81%
EPS 3Y-4.13%
EPS 5YN/A
EPS Q2Q%-23.48%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%17.57%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.86%
EBIT growth 3Y-10.65%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-60.5%
FCF growth 3Y-8.86%
FCF growth 5YN/A
OCF growth 1Y-60.5%
OCF growth 3Y-8.91%
OCF growth 5YN/A

RAYTECH HOLDING LTD / RAY FAQ

Can you provide the ChartMill fundamental rating for RAYTECH HOLDING LTD?

ChartMill assigns a fundamental rating of 6 / 10 to RAY.


Can you provide the valuation status for RAYTECH HOLDING LTD?

ChartMill assigns a valuation rating of 5 / 10 to RAYTECH HOLDING LTD (RAY). This can be considered as Fairly Valued.


Can you provide the profitability details for RAYTECH HOLDING LTD?

RAYTECH HOLDING LTD (RAY) has a profitability rating of 7 / 10.


Can you provide the financial health for RAY stock?

The financial health rating of RAYTECH HOLDING LTD (RAY) is 9 / 10.